Compositions for endodontic procedures
US-9351909-B2 · May 31, 2016 · US
US11141353B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11141353-B2 |
| Application number | US-201815996671-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 4, 2018 |
| Priority date | Jun 6, 2017 |
| Publication date | Oct 12, 2021 |
| Grant date | Oct 12, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A dental composition comprising a pre-reacted particulate mineral trioxide aggregate (MTA) dispersed in a polymer matrix wherein the content of MTA in the composition is in the range of 20 to 50 percent by weight based on the total weight of the composition.
Opening claim text (preview).
The invention claimed is: 1. A dental composition comprising a pre-reacted particulate of cured mineral trioxide aggregate (MTA) dispersed in a non-aqueous polymer matrix, wherein the content of cured particulate MTA is in the range of 20 to 50 by weight based on the total weight of the composition and wherein the pre-reacted particulate of cured MTA has an average particle size of from 0.1 to 100 microns; wherein the non-aqueous polymer matrix includes a silicone polymer or a polymerizable material selected from methacrylated polyisoprene, epoxy modified liquid polyisoprene or amine modified liquid polyisoprene. 2. The dental composition according to claim 1 , wherein the polymer matrix is present in an amount of 10 to 90 percent by weight based on the total weight of the composition. 3. The dental composition according to claim 1 , for use in endodontic treatment of a tooth. 4. The dental composition for use in the according to claim 3 , wherein the endodontic treatment is selected from the group consisting of root-end filling, apical plug for apexification, repair of root perforations, internal resorption, indirect pulp capping, direct pulp capping, obturation, and sealing the root canal. 5. The dental composition according to claim 1 , wherein the dental composition: (i) is bio inductive for cementum; (ii) stimulates a hard tissue covering where a blood supply exists thereby regenerating cementum creates a biological seal; (iii) does not stimulate an inflammatory process, (iv) supports tissue regeneration; (v) is biocompatible with pulp and periradicular tissues; and/or (vi) is not cytotoxic in the set or unset state. 6. The dental composition according to claim 1 , wherein the dental composition is antibacterial and/or antimicrobial due to a pH increase. 7. The dental composition according, to claim 1 , wherein the dental composition produces hydroxyapatite when exposed to either blood or simulated body fluid. 8. A process for the preparation of a dental composition comprising the steps of: (i) providing a cured mineral trioxide aggregate MTA; (ii) milling the cured MTA to an average particle size of from 0.1 to 100 microns to form a pre-reacted particulate of cured MTA; (iii) dispersing the pre-reacted particulate of cured MTA in a non-aqueous polymer matrix for forming a composite composition; wherein the non-aqueous polymer matrix includes a silicone polymer or a polymerizable material selected from methacrylated polyisoprene, epoxy modified liquid polyisoprene or amine modified liquid polyisoprene. 9. The process according to claim 8 , wherein the dental composition: (i) is bio inductive for cementum; (ii) stimulates a hard tissue covering where a blood supply exists thereby regenerating cementum creates a biological seal; (iii) does not stimulate an inflammatory process; (iv) supports tissue regeneration; (v) is biocompatible with pulp and periradicular tissues; and/or (vi) is not cytotoxic in the set or unset state. 10. The process according to claim 8 , wherein the dental composition is antibacterial and/or antimicrobial due to a pH increase. 11. The process according to claim 8 , wherein the dental composition produces hydroxyapatite when exposed to either blood or simulated body fluid.
Related publications grouped by family.
Answers are generated from the same data shown on this page.